Drug Shortage Active
HEPATOLITE is currently in shortage. Reason: Unavailable. This may impact manufacturing, supply chain, and quality hiring at the manufacturer.
Drug data last refreshed 19h ago · AI intelligence enriched 2w ago
HEPATOLITE is a radiopharmaceutical imaging agent containing Technetium Tc-99m Disofenin, used for hepatobiliary imaging to assess liver function and biliary tract patency. It is administered by injection and localizes in the liver and bile ducts, enabling scintigraphic visualization of hepatic clearance and biliary excretion.
Product faces imminent loss of exclusivity with declining franchise momentum; expect defensive commercial posturing and streamlined team structure.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
HEPATOLITE offers limited career growth opportunities due to its LOE-approaching status and current shortage; roles tend to focus on regulatory compliance, supply stabilization, and legacy brand maintenance rather than innovation or expansion. Professionals joining this franchise should expect a consolidation mindset and steady-state operational responsibilities.
Worked on HEPATOLITE at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.